Viral Vector Manufacturing Global Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~19% by 2028 | DelveInsight

New York, USA, May 30, 2023 (GLOBE NEWSWIRE) — Viral Vector Manufacturing Global Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~19% by 2028 | DelveInsight

The global viral vector manufacturing market is expected to grow positively in the coming years due to the rising incidence of serious genetic disorders such as spinal muscular atrophy, hemophilia, retinitis pigmentosa, and others, the rising incidence of different cancer types, increasing popularity and research on gene and cell therapy, and growing concern over the sudden occurrence of epidemics and pandemics.

DelveInsight’s Viral Vector Manufacturing Market Insights report provides the current and forecast market analysis, individual leading viral vector manufacturing companies’ market shares, challenges, viral vector manufacturing market drivers, barriers, trends, and key market viral vector manufacturing companies in the market.

Key Takeaways from the Viral Vector Manufacturing Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global viral vector manufacturing market during the forecast period. 
• Notable viral vector manufacturing companies such as Oxford Biomedica, Thermo Fisher Scientific Inc., Charles River Laboratories, FUJIFILM Diosynth Biotechnologies, Batavia Biosciences, CEVEC Pharmaceuticals GmbH, REGENXBIO Inc., BioNTech IMFS, AGC Biologics, ANDELYN BIOSCIENCES, INSTITUT MERIEUX, IDT Biologika, Lonza, Genezen, NecstGen, Avid Bioservices, Inc., Takara Bio Inc., VIROCELL BIOLOGICS, LTD., and several others, are currently operating in the viral vector manufacturing market.
• In August 2022, Thermo Fisher Scientific, the world leader in serving science, expanded its cell and gene therapy capabilities with the opening of its new viral vector manufacturing facility in Plainville, Mass.
• In October 2021, Merck, a leading science and technology company, announced the opening of its second Carlsbad, California-based facility, significantly expanding its global CDMO footprint.

To read more about the latest highlights related to the viral vector manufacturing market, get a snapshot of the key highlights entailed in the Global Viral Vector Manufacturing Market Report

Viral Vector Manufacturing Overview

Viral vectors are extensively utilized by molecular biologists to transport genetic elements into cells. Viruses evolve specialized molecular pathways for the efficient transport of their genomes into infected cells via the transduction process. Viral vectors are used to deliver genetic material into target cells in numerous genetic, vaccine, and molecular biology applications. Virus vectors are also used to explore new therapeutic regions. Viruses and animal or insect cell cultures are used to create viral vectors.

Viral Vector Manufacturing Market Insights

North America is expected to account for the highest proportion of the viral vector manufacturing market in 2023, out of all regions. The viral vector manufacturing market in the region is expected to grow significantly due to the importance of key growth factors such as the increasing patient population suffering from genetic disorders, the rising incidence of cancer, sophisticated healthcare infrastructure, the presence of key players, and rapid regulatory approval for new products.

Furthermore, various strategic viral vector manufacturing activities in the United States are expected to expand the viral vector manufacturing market during the forecast period. Kite, a Gilead Company, announced in October 2022 that the US FDA has authorized the company’s retroviral vector (RVV) manufacturing plant in Oceanside, California, for commercial production.

To know more about why North America is leading the market growth in the viral vector manufacturing market, get a snapshot of the Viral Vector Manufacturing Market Outlook 

Viral Vector Manufacturing Market Dynamics

The growing number of people with genetic abnormalities who are receiving treatment in the form of gene and cell therapy through the use of viral vectors is a major driver driving the growth of the viral vector manufacturing market. Furthermore, because viral vectors offer numerous advantages such as high gene transduction efficiency, precise delivery of genes to target cells, induction of robust immune responses, and increased cellular immunity, among others, they are regarded as an appealing and appropriate vehicle for cancer therapy, which is critical in managing the rising incidence of various cancer types such as blood cancer, bladder cancer, and others.

However, biosafety issues associated with viral vectors and challenges associated with viral vector manufacturing may limit the overall viral vector manufacturing market growth.

Additionally, the COVID-19 pandemic had a favorable impact on the viral vector manufacturing market. Due to the increase in the number of COVID-19 patients, a number of biotech and pharmaceutical businesses supported by the government and other significant organizations throughout the world were strongly focused on creating remedies in the form of COVID-19 vaccines. Later, firms such as AstraZeneca and Johnson & Johnson created COVID-19 vaccines that used viral vectors. Aside from these companies, many others are heavily involved in the development of viral vector-based vaccines for a variety of other indications. Nonetheless, the viral vector manufacturing market is expected to grow in the coming years.

Get a sneak peek at the viral vector manufacturing market dynamics @ Viral Vector Manufacturing Market Dynamics Analysis

Viral Vector Manufacturing Market Assessment

• Viral Vector Manufacturing Market Segmentation
  • Viral Vector Manufacturing Market Segmentation By  Type: Adenoviral Vectors, Adeno-Associated Viral (AAV) Vectors, Lentiviral Vectors, and Others
  • Viral Vector Manufacturing Market Segmentation By  Application: Gene Therapy, Cell Therapy, and Vaccines
  • Viral Vector Manufacturing Market Segmentation By  End User: Research Organizations, Biotech And Pharmaceutical Companies, and Others
  • Viral Vector Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the viral vector manufacturing market are set to emerge as the trendsetter explore @ Viral Vector Manufacturing Companies 

Table of Contents 

Interested in knowing the viral vector manufacturing market by 2028? Click to get a snapshot of the Viral Vector Manufacturing Market Trends

Related Reports

Adeno-Associated Virus Vectors in Gene Therapy Market

Adeno-Associated Virus Vectors in Gene Therapy Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key adeno-associated virus vectors in gene therapy companies, including Pfizer, CSL Behring, Spark Therapeutics, Freeline Therapeutics, RegenxBio, Amicus Therapeutics, among others.

Gene Therapy In CNS Disorder Market

Gene Therapy In CNS Disorder Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key gene therapy In CNS disorder companies, including UniQure Biopharma, Brain Neurotherapy Bio, NeuroGeneration, Eli Lilly and Company, Sio Gene Therapies, among others.

Gene Therapy For Ocular Rare Disease Pipeline

Gene Therapy For Ocular Rare Disease Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key gene therapy for ocular rare disease companies, including Roche Holding, Novartis, Ocugen, among others.

Gene Therapies For Cardiomyopathies Pipeline

Gene Therapies For Cardiomyopathies Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key gene therapies for cardiomyopathies companies, including XyloCor Therapeutics, LEXEO Therapeutics, Stelios Therapeutics, Tenaya Therapeutics, Renova Therapeutics, among others.

Gene And Cell Therapies Targeting CNS Disorders Pipeline

Gene And Cell Therapies Targeting CNS Disorders Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key gene and cell therapies targeting CNS disorders companies, including UniQure Biopharma, Brain Neurotherapy Bio, NeuroGeneration, Eli Lilly and Company, Sio Gene Therapies, among others.

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market

Related Healthcare Blogs

AAV Vectors in Gene Therapy

Emerging Gene Therapies

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.